開發雙前驅IFNr- Ipilimumab抗體以提升臨床癌症治療效果和安全性
Development of dual precursor IFNr-Ipilimumab antibodies to improve the efficacy and safety of clinical cancer treatment
莊智弘
Chuang Chih-Hung
健康科學院
College of Health Sciences
